Get the Stockscreener App
9.94
0.80%
-0.08
After Hours:
9.94
Enfusion Inc Stock (ENFN) Forecast
The Enfusion Inc (ENFN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.6382, representing a -43.28% decrease from the current price of $9.94. The highest analyst price target is $6.4033, and the lowest is $4.8731.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ENFN Price Target
Average 4.3222
(-56.52% Downside)
Is Enfusion Inc (ENFN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 58.59 | Neutral |
| STOCH(9,6) | 70.87 | Neutral |
| STOCHRSI(14) | 11.67 | Buy |
| MACD(12,26) | 0.2732 | Buy |
| ADX(14) | 37.78 | Buy |
| William %R | -46.27 | Neutral |
| CCI(14) | 18.58 | Neutral |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.963
Sell
|
9.9348
Buy
|
| MA20 |
9.649
Buy
|
9.7219
Buy
|
| MA50 |
9.3004
Buy
|
9.3357
Buy
|
| MA100 |
8.9157
Buy
|
9.1049
Buy
|
| MA200 |
8.9912
Buy
|
9.0207
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, ENFN could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on ENFN, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 58.59 indicates that ENFN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 70.87 indicates that ENFN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 11.67 indicates that ENFN is oversold. This suggests that ENFN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 37.78 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 18.58 indicates that ENFN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ENFN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Enfusion Inc financial reports and earnings history, Enfusion Inc (ENFN) stock could reach $4.3781 by 2030, $22.48 by 2040 and $50.70 by 2050. See the projected annual prices until 2050 of the Enfusion Inc stock below:
- Enfusion Inc (ENFN) is expected to reach an average price of $20.33 in 2035, with a high prediction of $20.36 and a low estimate of $19.59. This indicates an $104.56% rise from the last recorded price of $9.94.
- Enfusion Inc (ENFN) stock is projected to chart a bullish course in 2040, with an average price target of $21.50, representing an $116.26% surge from its current level. The forecast ranges from a conservative $21.81 to a sky-high $22.48.
- Our analysts predict Enfusion Inc (ENFN) to jump 244.83% by 2045, soaring from $34.42 to an average price of $34.28, potentially reaching $34.15. While $34.42 is the low estimate, the potential upside is significant.
- Enfusion Inc (ENFN) stock is expected to climb by 2050, reaching an average of $49.73, a $400.31% jump from its current level. However, a wide range of estimates exists, with high and low targets of $50.70 and $50.03, respectively, highlighting the market's uncertainty.
Enfusion Inc Stock (ENFN) Year by Year Forecast
Enfusion Inc Stock (ENFN) Price Forecast for 2025
Enfusion Inc Stock (ENFN) is expected to reach an average price of $4.3222 in 2025, with a high prediction of $7.6654 and a low estimate of $0.979. This indicates an -56.52% fall from the last recorded price of $9.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $5.7531 | $4.8731 | $6.4033 | -42.12% |
| February, 2025 | $7.4329 | $5.3456 | $7.5029 | -25.22% |
| March, 2025 | $6.9327 | $6.7478 | $7.6654 | -30.25% |
| April, 2025 | $5.745 | $5.715 | $7.2274 | -42.20% |
| May, 2025 | $6.4448 | $4.8474 | $6.5348 | -35.16% |
| June, 2025 | $5.7146 | $5.2797 | $7.0872 | -42.51% |
| July, 2025 | $7.0469 | $5.5471 | $7.2369 | -29.11% |
| August, 2025 | $6.853 | $6.4993 | $7.2067 | -31.06% |
| September, 2025 | $3.9347 | $3.3047 | $6.93 | -60.42% |
| October, 2025 | $2.2092 | $1.5043 | $4.0396 | -77.77% |
| November, 2025 | $1.6188 | $0.979 | $3.6341 | -83.71% |
| December, 2025 | $5.0033 | $1.4037 | $5.2233 | -49.66% |
Enfusion Inc Stock (ENFN) Price Forecast for 2026
The predicted value for Enfusion Inc (ENFN) in 2026 is set at an average of $3.5469. Estimates vary from a peak of $5.3963 to a trough of $1.6975, indicating an -64.32% surge from the present price of $9.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.6629 | $4.3982 | $5.3963 | -53.09% |
| February, 2026 | $2.1925 | $1.6975 | $4.7978 | -77.94% |
| March, 2026 | $2.8622 | $2.2123 | $3.0322 | -71.21% |
| April, 2026 | $2.9167 | $2.2871 | $3.512 | -70.66% |
| May, 2026 | $2.9063 | $2.0263 | $3.4016 | -70.76% |
| June, 2026 | $4.6359 | $2.5112 | $4.7059 | -53.36% |
| July, 2026 | $4.2304 | $3.9757 | $4.8808 | -57.44% |
| August, 2026 | $3.06 | $3.03 | $4.1953 | -69.22% |
| September, 2026 | $4.3245 | $2.1749 | $4.4645 | -56.49% |
| October, 2026 | $4.1541 | $2.6694 | $4.4941 | -58.21% |
| November, 2026 | $4.5237 | $3.794 | $4.7137 | -54.49% |
| December, 2026 | $2.87 | $2.50 | $4.7333 | -71.13% |
Enfusion Inc Stock (ENFN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Enfusion Inc (ENFN) is $1.1626, with a high forecast of $2.3129 and a low forecast of $0.0124. This indicates an -88.30% decrease from the last price of $9.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.2194 | $0.0124 | $1.2924 | -97.79% |
| February, 2027 | $1.0112 | $0.2532 | $0.9585 | -89.83% |
| March, 2027 | $1.3844 | $1.7492 | $1.5415 | -86.07% |
| April, 2027 | $1.895 | $0.295 | $2.115 | -80.94% |
| May, 2027 | $1.6044 | $1.3023 | $2.3129 | -83.86% |
| June, 2027 | $0.6188 | $0.7388 | $1.7518 | -93.77% |
| July, 2027 | $0.1094 | $0.3968 | $0.2715 | -98.90% |
| August, 2027 | $0.02 | $0.0174 | $0.61 | -99.80% |
| September, 2027 | $0.9268 | $0.1027 | $1.0068 | -90.68% |
| October, 2027 | $1.7462 | $0.8841 | $2.0962 | -82.43% |
| November, 2027 | $1.4956 | $1.2035 | $2.0009 | -84.95% |
| December, 2027 | $0.1177 | $0.345 | $1.4729 | -98.82% |
Enfusion Inc Stock (ENFN) Price Forecast for 2028
In 2028, Enfusion Inc (ENFN) is projected to reach an average price of $2.398, with a high projection of $4.737 and a low estimate of $0.0591. This indicates an -75.87% fall from the last price of $9.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.7017 | $0.2644 | $1.8417 | -82.88% |
| February, 2028 | $1.5812 | $0.0591 | $1.9212 | -84.09% |
| March, 2028 | $1.7079 | $1.2335 | $2.1906 | -82.82% |
| April, 2028 | $0.45 | $0.82 | $2.26 | -95.47% |
| May, 2028 | $3.381 | $3.0704 | $2.781 | -65.99% |
| June, 2028 | $4.7618 | $4.3412 | $4.1914 | -52.09% |
| July, 2028 | $4.5426 | $4.9126 | $4.737 | -54.30% |
| August, 2028 | $1.4635 | $1.7935 | $3.8728 | -85.28% |
| September, 2028 | $1.3343 | $1.4243 | $1.2943 | -86.58% |
| October, 2028 | $3.6151 | $2.1345 | $3.6649 | -63.63% |
| November, 2028 | $2.7861 | $3.0861 | $3.2553 | -71.97% |
| December, 2028 | $2.7769 | $2.9265 | $2.4613 | -72.06% |
Enfusion Inc Stock (ENFN) Price Forecast for 2029
The 2029 price forecast for Enfusion Inc Stock (ENFN) is $4.2229 on average, with a high prediction of $7.9325 and a low estimate of $0.5134. This represents an -57.52% decrease from the previous price of $9.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2979 | $1.9379 | $3.0473 | -86.94% |
| February, 2029 | $1.3386 | $1.1634 | $1.0381 | -86.53% |
| March, 2029 | $1.7194 | $1.2892 | $1.2494 | -82.70% |
| April, 2029 | $2.7902 | $2.2898 | $2.1302 | -71.93% |
| May, 2029 | $1.7712 | $1.551 | $2.7304 | -82.18% |
| June, 2029 | $1.012 | $1.327 | $1.7014 | -89.82% |
| July, 2029 | $0.8028 | $0.7726 | $0.8422 | -91.92% |
| August, 2029 | $6.0877 | $0.5134 | $5.3227 | -38.76% |
| September, 2029 | $6.6387 | $6.3655 | $6.0387 | -33.21% |
| October, 2029 | $8.1275 | $7.5865 | $7.9325 | -18.23% |
| November, 2029 | $7.1184 | $7.6834 | $7.8029 | -28.39% |
| December, 2029 | $4.5594 | $4.8894 | $6.6062 | -54.13% |
Enfusion Inc Stock (ENFN) Price Forecast for 2030
Enfusion Inc Stock (ENFN) is expected to reach an average price of $5.8085 in 2030, with a high forecast of $8.6303 and a low forecast of $2.9867. This signifies an -41.56% decrease from the last price of $9.94.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.0681 | $4.4704 | $4.3781 | -49.01% |
| February, 2030 | $6.3791 | $6.7314 | $6.6736 | -35.82% |
| March, 2030 | $5.7201 | $6.0201 | $6.1319 | -42.45% |
| April, 2030 | $5.6611 | $5.8356 | $5.3829 | -43.05% |
| May, 2030 | $4.1198 | $4.7598 | $5.9066 | -58.55% |
| June, 2030 | $4.1108 | $3.9481 | $3.8476 | -58.64% |
| July, 2030 | $4.7695 | $4.024 | $4.1995 | -52.02% |
| August, 2030 | $5.4505 | $4.9873 | $5.3905 | -45.17% |
| September, 2030 | $4.3815 | $4.1738 | $4.8683 | -55.92% |
| October, 2030 | $3.4902 | $3.7302 | $4.2992 | -64.89% |
| November, 2030 | $3.0712 | $3.2957 | $3.118 | -69.10% |
| December, 2030 | $9.3953 | $2.9867 | $8.6303 | -5.48% |
0.35%
2.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):